49 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
8 Jan 20
Rhythm Pharmaceuticals Announces Leadership Transition
4:00pm
Exhibit 99.1
Rhythm Pharmaceuticals Announces Leadership Transition
Keith Gottesdiener, M.D. to Step Down as Chief Executive Officer Following NDA … to thank Keith for his significant contributions to Rhythm,” said David Meeker, M.D., Chairman of the Board. “Under Keith’s leadership, Rhythm has
8-K
EX-99.1
gxl u83wujit
3 Feb 21
Regulation FD Disclosure
12:00am
DEF 14A
t9ixcunmh7s
30 Apr 18
Definitive proxy
4:01pm
8-K
7061 8k7v
30 Mar 20
Departure of Directors or Certain Officers
5:20pm
8-K
ia52ncyubpp48msx
25 Jul 19
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
4:01pm
8-K
EX-99.1
64zk 8auelltpov9
25 Jul 19
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
4:01pm
8-K
EX-99.1
0k56m f2m1
3 Aug 21
Rhythm Pharmaceuticals Reports Second Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
wwe7zqnm8i4 he
10 Jan 20
Regulation FD Disclosure
8:46am
8-K
EX-99.1
ho9nkqe64v6s y2c2
2 Nov 21
Rhythm Pharmaceuticals Reports Third Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
23k pkk237imyf
2 Nov 20
Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
9:32am
8-K
EX-99.1
cxppu g1cv
6 Apr 22
Regulation FD Disclosure
8:01am
8-K
EX-99.2
t90uggc5cfow
25 Sep 19
Rhythm Pharmaceuticals Provides Update on Research and Development Programs
8:30am
8-K
EX-99.1
b10t6adng6lzpr56tq3r
8 Nov 22
Rhythm Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Update
7:03am